The University of Chicago Header Logo

Connection

Geoffrey Wool to Humans

Back to Details
This is a "connection" page, showing publications Geoffrey Wool has written about Humans.
Geoffrey Wool
Connection Strength
0.624
Humans
  1. Dilute Russell viper venom time interpretation: Influence of lot changes and normalization. Am J Clin Pathol. 2024 Oct 03; 162(4):426-428.
    View in: PubMed
    Score: 0.031
  2. The utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testing. Am J Clin Pathol. 2024 Oct 03; 162(4):379-391.
    View in: PubMed
    Score: 0.031
  3. Sensitivity and specificity of thromboelastography for hyperfibrinolysis: Comparison of TEG 5000 and TEG 6S CK LY30 systems. Am J Clin Pathol. 2023 11 02; 160(5):455-465.
    View in: PubMed
    Score: 0.030
  4. Viscoelastic testing: Critical appraisal of new methodologies and current literature. Int J Lab Hematol. 2023 Oct; 45(5):643-658.
    View in: PubMed
    Score: 0.029
  5. Decreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology. J Card Surg. 2022 Dec; 37(12):5011-5018.
    View in: PubMed
    Score: 0.028
  6. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion. 2022 07; 62(7):1446-1451.
    View in: PubMed
    Score: 0.027
  7. Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy. Transfusion. 2022 04; 62(4):916-918.
    View in: PubMed
    Score: 0.026
  8. The Effect of RBC Transfusion on Oxygenation Status. Am J Clin Pathol. 2022 03 03; 157(3):477.
    View in: PubMed
    Score: 0.026
  9. Comparison of Viscoelastic Testing by Rotational Torsion and Harmonic Resonance Methods. Am J Clin Pathol. 2021 Oct 13; 156(5):818-828.
    View in: PubMed
    Score: 0.026
  10. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2021; 88(1):15-27.
    View in: PubMed
    Score: 0.024
  11. Basic principles of viscoelastic testing. Transfusion. 2020 10; 60 Suppl 6:S1-S9.
    View in: PubMed
    Score: 0.024
  12. How I investigate bone marrow necrosis. Int J Lab Hematol. 2019 Oct; 41(5):585-592.
    View in: PubMed
    Score: 0.022
  13. Impact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing. Hematol Oncol Clin North Am. 2019 10; 33(5):797-811.
    View in: PubMed
    Score: 0.022
  14. Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review. Am J Clin Pathol. 2019 01 01; 151(1):1-17.
    View in: PubMed
    Score: 0.021
  15. Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. J Clin Apher. 2019 Feb; 34(1):64-72.
    View in: PubMed
    Score: 0.021
  16. Acquired factor XI deficiency and therapeutic plasma exchange. J Clin Apher. 2018 Jun; 33(3):427-430.
    View in: PubMed
    Score: 0.019
  17. Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism. Transfusion. 2017 07; 57(7):1827-1832.
    View in: PubMed
    Score: 0.019
  18. Bone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. Am J Clin Pathol. 2015 Feb; 143(2):201-13; quiz 306.
    View in: PubMed
    Score: 0.016
  19. Pathology consultation on anticoagulation monitoring: factor X-related assays. Am J Clin Pathol. 2013 Nov; 140(5):623-34.
    View in: PubMed
    Score: 0.015
  20. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res. 2009 Sep; 50(9):1889-900.
    View in: PubMed
    Score: 0.011
  21. The influence of acute phase proteins on murine atherosclerosis. Curr Drug Targets. 2007 Nov; 8(11):1203-14.
    View in: PubMed
    Score: 0.010
  22. Ratios of calcium to citrate administration in blood transfusion for traumatic hemorrhage: A retrospective cohort study. Transfusion. 2024 Nov; 64(11):2104-2113.
    View in: PubMed
    Score: 0.008
  23. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. Am J Clin Pathol. 2024 Sep 03; 162(3):233-242.
    View in: PubMed
    Score: 0.008
  24. Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential. Air Med J. 2024 Jul-Aug; 43(4):348-356.
    View in: PubMed
    Score: 0.008
  25. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic? Blood Adv. 2023 08 08; 7(15):4112-4123.
    View in: PubMed
    Score: 0.007
  26. Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.
    View in: PubMed
    Score: 0.007
  27. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. Blood. 2022 12 22; 140(25):2722-2729.
    View in: PubMed
    Score: 0.007
  28. Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program. Semin Thromb Hemost. 2022 Sep; 48(6):690-699.
    View in: PubMed
    Score: 0.007
  29. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies. Am J Hematol. 2022 05; 97(5):519-526.
    View in: PubMed
    Score: 0.007
  30. (More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy. PLoS One. 2022; 17(1):e0261567.
    View in: PubMed
    Score: 0.007
  31. Interlaboratory Performance in Measurement of Dabigatran and Rivaroxaban. Arch Pathol Lab Med. 2022 01 02; 146(2):145-153.
    View in: PubMed
    Score: 0.006
  32. Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi. Sci Rep. 2021 11 23; 11(1):22805.
    View in: PubMed
    Score: 0.006
  33. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J Clin Apher. 2022 Feb; 37(1):117-121.
    View in: PubMed
    Score: 0.006
  34. Functional Assessment of Platelet Dense Granule ATP Release. Am J Clin Pathol. 2021 05 18; 155(6):863-872.
    View in: PubMed
    Score: 0.006
  35. Platelet-rich aggregates in MNC collection circuit. Transfusion. 2021 04; 61(4):1010-1011.
    View in: PubMed
    Score: 0.006
  36. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.006
  37. The Point-of-Care INR Test for Vitamin K Antagonist Monitoring. JAMA. 2019 12 03; 322(21):2129-2130.
    View in: PubMed
    Score: 0.006
  38. Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation. HLA. 2019 09; 94(3):307-311.
    View in: PubMed
    Score: 0.005
  39. Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review. Int J Lab Hematol. 2019 Feb; 41(1):80-86.
    View in: PubMed
    Score: 0.005
  40. Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB. Transfusion. 2018 08; 58(8):1965-1972.
    View in: PubMed
    Score: 0.005
  41. The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review. J Clin Apher. 2018 Jun; 33(3):371-379.
    View in: PubMed
    Score: 0.005
  42. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva. Bone. 2018 04; 109:104-110.
    View in: PubMed
    Score: 0.005
  43. A superior method for cell block preparation for fine-needle aspiration biopsies. Cancer Cytopathol. 2016 Jul; 124(7):508-18.
    View in: PubMed
    Score: 0.004
  44. Biological properties of apolipoprotein a-I mimetic peptides. Curr Atheroscler Rep. 2010 Mar; 12(2):96-104.
    View in: PubMed
    Score: 0.003
  45. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des. 2010; 16(28):3173-84.
    View in: PubMed
    Score: 0.003
  46. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol. 2009 Jun; 20(3):171-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.